نتائج البحث

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).

• Authors : Kosmas CE; Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY 10033, USA.

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors* ; Hyperlipoproteinemias* ; Aortic Valve Stenosis*

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 03; Vol. 24 (17). Date of Electronic Publication: 2023 Sep 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany

• Source: A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Assessing the Reduction of the Rate of Lipoprotein Apheresis After Treatment With Pelacarsen (TQJ230) Compared to Placebo in Patients

تفاصيل العنوان

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

• Authors : Hunan Provincial People's Hospital

• Source: A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics (Biomarkers) of ASC41 Tables in Overweight and Obese Subjects

تفاصيل العنوان

Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

• Authors : Hunan Provincial People's Hospital

• Source: A Randomized, Single Center, Open-label, Phase I Study to Evaluate the Effect of Food and Fasting on the Pharmacokinetics of ASC41 Tablets in Healthy Volunteers

تفاصيل العنوان

Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink

• Authors : Chunjian Li, Director of Cardiology

• Source: Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special DrinkBenjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain

تفاصيل العنوان

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. (BROOKLYN)

• Source: A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH Who Are Not Adequately Controlled by Their Lipid

تفاصيل العنوان

Plant Sterol-Enriched Palm Oil to Improve Lipid Profile and Inflammation in Hyperlipidemic Individuals

• Authors : BASF; Mira Dewi, Dr, Assistant Professor, Principal Investigator, Head of Health and Nutrition Division at Seafast Center IPB

• Source: Effect of Plant Sterol-Enriched Palm Oil on Lipid Profile and Systemic Inflammation in Hyperlipidemic Adults: A Placebo-Controlled Double-Blinded Trial

تفاصيل العنوان

Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

• Source: Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)Shah NN, Ghazi L, Yamamoto Y, Martin M, Simonov M, Riello RJ, Faridi KF, Ahmad T, Wilson FP, Desai NR.

تفاصيل العنوان

Elevated Lipoprotein(a) in Hospital Staff (LPACO)

• Authors : Loh Wann Jia, Primary Investigator and Consultant Endocrinologist.

• Source: Investigating The Prevalence and Clinical Significance of Elevated Lipoprotein(a) Blood Levels in Hospital StaffLoh WJ, Watts GF. Detection strategies for elevated lipoprotein(a): will

تفاصيل العنوان

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) (ENHANCE)

• Authors : Merck Sharp & Dohme LLC

• Source: Effect of Combination Ezetimibe and High-Dose Simvastatin vs Simvastatin Alone on the Atherosclerotic Process in Subjects With Heterozygous Familial Hypercholesterolemia (The ENHANCE Trial)

تفاصيل العنوان